AGR.L

Assura Plc
Assura plc - Director/PDMR Shareholding
9th December 2024, 08:30
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3198P
Assura PLC
09 December 2024
 

9 December 2024

Assura plc

("the Company")

Notifications of transactions by Persons Discharging Managerial Responsibilities ("PDMRs")

The Company announces that on 5 December 2024 the following named PDMRs acquired partnership shares and were awarded matching shares and free shares over ordinary shares of 10 pence each in the Company under the Company's Share Incentive Plan ("SIP").

PDMR

Position

Number of partnership shares acquired

Number of matching shares awarded

Shareholding of PDMR and PCAs post acquisition and award

Jonathan Murphy

CEO

369

431

3,327,792

Jayne Cottam

CFO

369

431

952,937

Orla Ball

General Counsel

369

431

39,635

Robert James

Group Development Director

371

432

30,723

Sarah Taylor

Chief People Officer

372

434

19,807

The Notification of Dealing Form for each PDMR can be found below.

This notification is made in accordance with the Market Abuse Regulation.

 

Notification of dealing form

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jonathan Murphy

2

Reason for the notification

 

a)

Position/status

 

CEO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4056 GBP

 

 

800

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4056 GBP

 

 

800

 

£324.48 GBP

e)

Date of the transaction

 

5 December 2024

f)

Place of the transaction

 

XLON

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Jayne Cottam

2

Reason for the notification

 

a)

Position/status

 

CFO

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4056 GBP

 

 

800

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4056 GBP

 

 

800

 

£324.48 GBP

e)

Date of the transaction

 

5 December 2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Orla Ball

2

Reason for the notification

 

a)

Position/status

 

General Counsel

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4056 GBP

 

 

800

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4056 GBP

 

 

800

 

£324.48 GBP

e)

Date of the transaction

 

5 December 2024

f)

Place of the transaction

 

XLON

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Robert James

2

Reason for the notification

 

a)

Position/status

 

Group Development Director

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4056 GBP

 

 

803

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4056 GBP

 

 

803

 

£325.70 GBP

e)

Date of the transaction

 

5 December 2024

f)

Place of the transaction

 

XLON

 

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

 

Sarah Taylor

2

Reason for the notification

 

a)

Position/status

 

Chief People Officer

b)

Initial notification/ Amendment

 

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name

 

Assura plc

b)

LEI

 

21380026T19N2Y52XF72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument

 

Identification code

Ordinary shares of 10 pence each

 

 

 

 

 

GB00BVGBWW93

b)

Nature of the transaction

 

 

Acquisition of partnership shares and award of matching shares under the SIP

 

 

 

 

 

c)

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

 

£0.4056 GBP

 

 

806

 

 

 

d)

Aggregated information

 

-      Aggregated volume

 

-    Price

 

 

 

 

 

Aggregate Price

Aggregate Volume

Aggregate Total

 

£0.4056 GBP

 

 

806

 

£326.91 GBP

e)

Date of the transaction

 

5 December 2024

f)

Place of the transaction

 

XLON

 

For more information, please contact:

 

Assura plc

 

Tel: 0161 515 2043

David Purcell, Investor Relations Director

 

Email: Investor@assura.co.uk

FGS Global

Gordon Simpson

Tel: 0207 251 3801

Email: Assura@fgsglobal.com

 

Notes to Editors

Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health outcomes through its portfolio of more than 600 healthcare buildings, from which over six million patients are served.

A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA* indices and has a secondary listing on the Johannesburg Stock Exchange. As at 30 September 2024, Assura's portfolio was valued at £3.2 billion and has a strong track record of growing financial returns and dividends for shareholders.

At Assura we BUILD for health and as the first FTSE 250 certified B Corp we are committed to keeping ESG at the heart of our strategy, creating Healthy Environments (E) and Healthy Communities (S) and maintaining a Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGIBDDIBGDGSC]]>
TwitterFacebookLinkedIn